Clinical Trial Update: Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing EXPAREL to standard of care for pain management in elective cesarean section; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elective Cesarean Section
• Pain Management

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Elective Cesarean Section, Pain Management | Phase 4 | Status: COMPLETED | Results posted: 2022-07-18